146 related articles for article (PubMed ID: 31898000)
21. Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction.
Tran TV; Djaileb L; Riou L; Lantuejoul LR; Giai J; Barone-Rochette G
Microcirculation; 2024 Feb; 31(2):e12843. PubMed ID: 38174616
[TBL] [Abstract][Full Text] [Related]
22. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
[TBL] [Abstract][Full Text] [Related]
23. The detection of apical variant of hypertrophic cardiomyopathy in myocardial perfusion imaging.
Akbulut A; Kalayci S; Koca G; Yigit H; Korkmaz M
Acta Cardiol; 2019 Dec; 74(6):544-546. PubMed ID: 30650023
[No Abstract] [Full Text] [Related]
24. Impaired myocardial accumulation of 15-(p-iodophenyl)-9-(R,S)-methylpentadecanoic acid in a patient with hypertrophic cardiomyopathy and exercise-induced ischemia due to vasospasm.
Doi A; Nakata T; Obara F; Kyuma M; Tsuchihashi K; Fujimori K; Shimamoto K
Ann Nucl Med; 2000 Feb; 14(1):57-61. PubMed ID: 10770582
[TBL] [Abstract][Full Text] [Related]
25. [Clinical usefulness of ECG-gated SPECT].
Takahashi N
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2004 Mar; 60(3):341-5. PubMed ID: 15131501
[No Abstract] [Full Text] [Related]
26. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
[TBL] [Abstract][Full Text] [Related]
27. Clinical topic: Nuclear imaging in hypertrophic cardiomyopathy.
Delgado V; Bax JJ
J Nucl Cardiol; 2015 Jun; 22(3):408-18. PubMed ID: 25548121
[TBL] [Abstract][Full Text] [Related]
28. Myocardial metabolic changes in hypertrophic cardiomyopathy.
Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
[TBL] [Abstract][Full Text] [Related]
29. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging in cardiology: current status and perspectives.
Fedele F; Di Renzi P; Di Cesare E
Cardiologia; 1996 Jul; 41(7):595-611. PubMed ID: 8831179
[No Abstract] [Full Text] [Related]
31. Severe Late-Onset Fabry Cardiomyopathy Unmasked by a Multimodality Imaging Approach.
Visoiu IS; Ciobanu AO; Nicula AI; Iascone M; Jurcut R; Vinereanu D; Rimbas RC
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009709. PubMed ID: 31630529
[No Abstract] [Full Text] [Related]
32. An Unexpected Cause of Trauma-related Myocardial Infarction: Multimodality Assessment of Right Coronary Artery Dissection.
Ngam PI; Ong CC; Koo CC; Loh PH; Loo LM; Teo LL
Ann Acad Med Singap; 2018 Jul; 47(7):269-271. PubMed ID: 30120437
[No Abstract] [Full Text] [Related]
33. Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
Habib M; Hoss S; Rakowski H
Curr Cardiol Rep; 2019 Jun; 21(8):75. PubMed ID: 31243594
[TBL] [Abstract][Full Text] [Related]
34. [Exercise myocardial scintigraphy of hypertrophic cardiomyopathy--clinical significance of redistribution].
Uruma M; Ojima K; Tsuda T; Aizawa Y; Arai Y; Shibata A; Kimura M; Odano I; Sakai K; Mitani T
Kaku Igaku; 1985 Jun; 22(6):831-7. PubMed ID: 4057685
[No Abstract] [Full Text] [Related]
35. SPECT Myocardial Perfusion Imaging in the Diagnosis of Apical Hypertrophic Cardiomyopathy.
Masrur S; Memon S; Chhabra L; Parker MW; Duvall L
Tex Heart Inst J; 2016 Oct; 43(5):467-468. PubMed ID: 27777539
[No Abstract] [Full Text] [Related]
36. No reflow-like pattern in intramyocardial coronary artery suggests myocardial ischemia in patients with hypertrophic cardiomyopathy.
Kim WS; Minagoe S; Mizukami N; Zhou X; Yoshinaga K; Takasaki K; Yuasa T; Kihara K; Hamasaki S; Otsuji Y; Kisanuki A; Tei C
J Cardiol; 2008 Aug; 52(1):7-16. PubMed ID: 18639772
[TBL] [Abstract][Full Text] [Related]
37. Myocardial bridges at multiple sites over the left coronary artery in a patient with hypertrophic cardiomyopathy.
Voelker W; Schick KD; Karsch KR
Int J Cardiol; 1989 May; 23(2):258-60. PubMed ID: 2722293
[TBL] [Abstract][Full Text] [Related]
38. Malignant anomalous right coronary artery associated with mid-cavitary hypertrophic obstructive cardiomyopathy.
Mohanan Nair KK; Gopalakrishnan A; Avinash Inamdar S; Valaparambil A; Kapilamoorthy TR; Tharakan JA
Postgrad Med J; 2016 May; 92(1087):306. PubMed ID: 26831321
[No Abstract] [Full Text] [Related]
39. Reversible ischaemia in hypertrophic cardiomyopathy.
Thomson H; Fong W; Stafford W; Frenneaux M
Br Heart J; 1995 Sep; 74(3):220-3. PubMed ID: 7547013
[TBL] [Abstract][Full Text] [Related]
40. Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".
Huang G; Fadl SA; Sukhotski S; Matesan M
Int J Cardiovasc Imaging; 2020 Mar; 36(3):553-561. PubMed ID: 31853820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
